Background
Methods
Results
Study group (total) | SARS-CoV‑2 negative | SARS-CoV‑2 positive | p-value | |
---|---|---|---|---|
Number of subjects | 311 (100.0%) | 299 (96.1%) | 12 (3.9%) | – |
Number of male subjects | 92 (29.6%) | 88 (29.4%) | 4 (33.3%) | 0.772 |
Mean age in years (min–max) | 82.0 ± 11.0 (46.4–105.7) | 81.8 ± 11.0 (46.4–101.6) | 88.5 ± 9.4 (69.9–105.7) | 0.051 |
Number of subtrochanteric femoral fractures | 17 (5.5%) | 17 (5.7%) | 0 (0.0%) | 0.680 |
Number of pertrochanteric femoral fractures | 156 (50.1%) | 150 (50.2%) | 6 (50.0%) | |
Number of fractures of the femoral neck | 138 (44.4%) | 132 (44.1%) | 6 (50.0%) | |
Mean length of stay in daysa (min–max) | 11.6 ± 6.7 (5–57) | 11.5 ± 6.5 (5–57) | 15.6 ± 13.1 (7–42) | 0.683 |
Number of deceased patients | 21 (6.8%) | 16 (5.4%) | 5 (41.7%) | <0.001 |
Mean postoperative period to death in days (min–max) | 8.4 ± 4.9 (1–20) | 8.5 ± 5.6 (1–20) | 8.2 ± 1.6 (6–10) | 0.851 |
Median ASA Scorea (min–max) | 3 (1–4) | 3 (1–4) | 3 (2–4) | 0.990 |
Median ASA Score of deceased patients (min–max) | 3 (2–4) | 3 (2–4) | 3 (2–3) | 0.719 |
Cause of death of COVID-19 negative patients | Absolute frequency | Relative frequency (%) |
---|---|---|
Cardiac decompensation with myocardial failure | 7 | 43.75 |
Pulmonary embolism | 2 | 12.5 |
Non-COVID-19 pneumonia | 2 | 12.5 |
Acute myocardial infarction | 1 | 6.25 |
Sepsis | 1 | 6.25 |
Gastrointestinal bleeding | 1 | 6.25 |
Epileptic shock with aspiration | 1 | 6.25 |
Hepatic failure | 1 | 6.25 |
SARS-CoV‑2 positive patients (n = 12) | SARS-CoV‑2 negative patients (n = 299) | |||||
---|---|---|---|---|---|---|
Deceased | Alive | p-value | Deceased | Alive | p-value | |
Number of subjects | 5 (41.7%) | 7 (58.3%) | – | 16 (5.4%) | 283 (94.6%) | – |
Mean age in years (min–max) | 95.5 ± 7.5 (85.1–105.7) | 83.5 ± 7.3 (69.9–92.1) | 0.020 | 83.5 ± 10.9 (66.2–96.0) | 81.7 ± 11.0 (46.4–101.6) | 0.324 |
Median ASA Score (min–max) | 3 (2–3) | 3 (2–4) | 1.000 | 3 (2–4) | 3 (1–4) | 0.419 |
Number of regional anesthesia | 2/5 (40.0%) | 5/7 (71.4%) | 0.276 | 7/16 (43.8%) | 105/283 (37.1%) | 0.593 |